# CLYM (Climb Bio, Inc.) - SEC EDGAR Financial Statements

> Climb Bio, Inc. reported $236.6M in total assets and a net loss of $59.31M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/CLYM
- Markdown: https://convexityos.com/fundamentals/CLYM.md
- SEC CIK: 0001768446
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:33 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001768446&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$66.76M | Operating profit |
| Net Income | FY 2025 | -$59.31M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.74 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$54.54M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $205.4M | Total debt: $1.07M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $46.71M | $14.34M | $15.41M | $26.21M | $23.32M | $8.77M |
| Total Operating Expenses | $67.88M | $82.02M | $40.27M | $45.13M | $35.67M | $20.93M |
| **Operating Income** | -$67.88M | -$82.02M | -$40.27M | -$45.13M | -$35.67M | -$20.93M |
| **EBITDA** | -$67.79M | -$82.02M | -- | -- | -- | -- |
| Interest Income | $8.32M | $8.13M | $4.62M | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$59.85M | -$73.90M | -$35.12M | -$45.24M | -$47.48M | -$20.67M |
| Basic EPS | -$0.88 | -$1.53 | -$1.30 | -$1.72 | -$4.24 | -$10.49 |
| **Diluted EPS** | -$0.88 | -$1.53 | -$1.30 | -$1.72 | -$4.24 | -$10.49 |
| Basic Shares Outstanding | 67.8M | 48.2M | 27.0M | 26.3M | 12.3M | 2.2M |
| Diluted Shares Outstanding | 67.8M | 48.2M | 27.0M | 26.3M | 12.3M | 2.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $11.04M | $9.71M | $9.37M | $13.74M | $9.07M | $6.58M | $17.33M | $5.96M |
| Total Operating Expenses | $16.89M | $15.36M | $15.21M | $19.30M | $14.89M | $10.68M | $23.02M | $10.91M |
| **Operating Income** | -$16.89M | -$15.36M | -$15.21M | -$19.30M | -$14.89M | -$10.68M | -$23.02M | -$10.91M |
| **EBITDA** | -$16.70M | -$15.33M | -$15.17M | -$19.27M | -$14.86M | -$10.64M | -$23.02M | -- |
| Interest Income | $2.33M | $1.85M | $1.51M | $1.83M | $2.04M | $2.17M | $2.29M | -- |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | $0 | $0 |
| **Net Income** | -$14.57M | -$13.50M | -$13.72M | -$17.52M | -$12.89M | -$8.67M | -$20.78M | -$8.42M |
| Basic EPS | -$0.18 | -$0.18 | -$0.20 | -- | -$0.19 | -$0.13 | -$0.31 | -- |
| **Diluted EPS** | -$0.18 | -$0.18 | -$0.20 | -- | -$0.19 | -$0.13 | -$0.31 | -- |
| Basic Shares Outstanding | 80.0M | 76.2M | 68.2M | -- | 68.0M | 67.6M | 67.5M | -- |
| Diluted Shares Outstanding | 80.0M | 76.2M | 68.2M | -- | 68.0M | 67.6M | 67.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $35.69M | $87.23M | $93.11M | $43.59M | $46.92M | $20.49M |
| Short-Term Investments | $65.39M | $63.69M | $13.69M | $79.98M | $89.56M | $0 |
| **Cash & Short-Term Investments** | $160.7M | $150.9M | $106.8M | $123.6M | $161.4M | $20.49M |
| **Total Current Assets** | $105.8M | $154.9M | $110.3M | $134.4M | $148.3M | $22.00M |
| Property, Plant & Equipment, Net | $288K | $199K | -- | -- | -- | -- |
| Long-Term Investments | $59.57M | $61.61M | $0 | $0 | $24.92M | $0 |
| Other Non-Current Assets | $1.53M | $16K | $15K | $128K | $70K | $2.63M |
| **Total Non-Current Assets** | $61.90M | $62.31M | $214K | $599K | $24.99M | $2.63M |
| **Total Assets** | $167.7M | $217.2M | $110.5M | $135.0M | $173.2M | $24.63M |
| Accounts Payable | $2.27M | $705K | $66K | $750K | $1.40M | $1.09M |
| Other Current Liabilities | -- | $31K | $138K | $0 | -- | -- |
| **Total Current Liabilities** | $6.98M | $4.93M | $2.83M | $6.10M | $6.03M | $3.06M |
| Other Non-Current Liabilities | -- | $0 | $22K | $0 | $7.0K | $0 |
| **Total Non-Current Liabilities** | $285K | $375K | $37K | $180K | $7.0K | $0 |
| **Total Liabilities** | $7.27M | $5.31M | $2.87M | $6.28M | $6.04M | $3.06M |
| **Total Debt (incl. Leases)** | $541K | $532K | $349K | $480K | -- | -- |
| Common Stock | $5.0K | $7.0K | $3.0K | $3.0K | $3.0K | $1.0K |
| Retained Earnings | -$289.7M | -$229.9M | -$156.0M | -$120.9M | -$75.62M | -$28.14M |
| Accumulated Other Comp. Income | $435K | $23K | -$2.0K | -$358K | -$123K | $0 |
| **Total Stockholders' Equity** | $160.5M | $211.9M | $107.6M | $128.7M | $167.2M | -$24.98M |
| Total Equity | $160.5M | $211.9M | $107.6M | $128.7M | $167.2M | -$24.98M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $39.73M | $44.11M | $8.36M | $35.69M | $25.80M | $22.68M | $29.02M | $87.23M |
| Short-Term Investments | $165.7M | $139.0M | $101.2M | $65.39M | $61.10M | $62.02M | $69.04M | $63.69M |
| **Cash & Short-Term Investments** | $205.4M | $183.1M | $109.6M | $160.7M | $86.90M | $84.70M | $98.06M | $150.9M |
| **Total Current Assets** | $210.1M | $186.6M | $113.4M | $105.8M | $90.96M | $87.38M | $100.3M | $154.9M |
| Property, Plant & Equipment, Net | $1.33M | $695K | $250K | $288K | $318K | $314K | -- | $199K |
| Long-Term Investments | $22.20M | $56.10M | $36.74M | $59.57M | $88.93M | $102.7M | $99.78M | $61.61M |
| Other Non-Current Assets | $1.89M | $1.65M | $1.53M | $1.53M | $1.53M | $1.37M | $226K | $16K |
| **Total Non-Current Assets** | $26.41M | $59.66M | $38.97M | $61.90M | $91.34M | $105.0M | $100.5M | $62.31M |
| **Total Assets** | $236.6M | $246.3M | $152.4M | $167.7M | $182.3M | $192.4M | $200.7M | $217.2M |
| Accounts Payable | $1.06M | $1.13M | $860K | $2.27M | $477K | $946K | $777K | $705K |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $31K |
| **Total Current Liabilities** | $7.91M | $5.93M | $4.07M | $6.98M | $4.95M | $6.21M | $7.04M | $4.93M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Liabilities** | $605K | $813K | $216K | $285K | $352K | $417K | $319K | $375K |
| **Total Liabilities** | $8.51M | $6.75M | $4.29M | $7.27M | $5.30M | $6.62M | $7.36M | $5.31M |
| **Total Debt (incl. Leases)** | $1.07M | $1.31M | $479K | $541K | $580K | $639K | $474K | $532K |
| Common Stock | $6.0K | $6.0K | $5.0K | $5.0K | $7.0K | $7.0K | $7.0K | $7.0K |
| Retained Earnings | -$331.5M | -$316.9M | -$303.4M | -$289.7M | -$272.2M | -$259.3M | -$250.7M | -$229.9M |
| Accumulated Other Comp. Income | -$528K | -$67K | $157K | $435K | $469K | $318K | $286K | $23K |
| **Total Stockholders' Equity** | $228.1M | $239.5M | $148.1M | $160.5M | $177.0M | $185.8M | $193.4M | $211.9M |
| Total Equity | $228.1M | $239.5M | $148.1M | $160.5M | $177.0M | $185.8M | $193.4M | $211.9M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$59.85M | -$73.90M | -$35.12M | -$45.24M | -$47.48M | -$20.67M |
| Depreciation & Amortization | $97K | $0 | -- | -- | -- | -- |
| Stock-Based Compensation | $8.05M | $5.56M | $12.81M | $6.99M | $3.74M | $707K |
| Change in Payables | $1.56M | -$963K | -$686K | -$653K | $318K | -$167K |
| **Operating Cash Flow** | -$54.36M | -$15.56M | -$20.60M | -$37.37M | -$36.07M | -$14.10M |
| Capital Expenditure | -$186K | $0 | $0 | -- | -- | -- |
| **Free Cash Flow** | -$54.54M | -$15.56M | -$20.60M | -- | -- | -- |
| Acquisitions, Net | $0 | -$4.64M | -- | -- | -- | -- |
| Purchases of Investments | -$108.1M | -$132.2M | -$58.45M | -$87.96M | -$115.0M | -- |
| **Investing Cash Flow** | $2.83M | -$121.1M | $68.98M | $34.44M | -$115.0M | $8.08M |
| Common Stock Issued | -- | $10.98M | $841K | $0 | $149K | -- |
| **Financing Cash Flow** | -$21K | $130.7M | $841K | $0 | $177.2M | $4.92M |
| **Net Change in Cash** | -$51.54M | -$5.88M | $49.53M | -$3.34M | $26.43M | -$736K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$14.57M | -$13.50M | -$13.72M | -$17.52M | -$12.89M | -$8.67M | -$20.78M | -$8.42M |
| Depreciation & Amortization | $195K | $33K | $38K | $30K | $29K | $38K | $0 | -- |
| Stock-Based Compensation | $2.04M | $1.48M | $1.60M | $1.04M | $3.98M | $1.01M | $2.02M | $1.66M |
| Change in Payables | -$67K | $200K | -$1.41M | $1.79M | -$393K | $93K | $72K | $414K |
| **Operating Cash Flow** | -$12.00M | -$10.55M | -$14.38M | -$15.63M | -$12.14M | -$11.15M | -$15.43M | -$5.52M |
| Purchases of Investments | -$36.79M | -$82.61M | -$44.85M | -$5.00M | -$23.71M | -$20.62M | -$58.75M | -$60.41M |
| **Investing Cash Flow** | $6.40M | -$57.26M | -$12.96M | $25.54M | $15.26M | $4.79M | -$42.75M | -$53.41M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | $0 | $41K |
| **Financing Cash Flow** | $1.22M | $103.7M | $5.0K | -$21K | $0 | $0 | $0 | $41K |
| **Net Change in Cash** | -$4.38M | $35.89M | -$27.33M | $9.88M | $3.12M | -$6.34M | -$58.21M | -$58.95M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -37.3% | -34.9% | -32.6% | -35.2% | -28.4% | -- |
| Return on Assets (ROA) | -35.7% | -34.0% | -31.8% | -33.5% | -27.4% | -83.9% |
| Current Ratio | 15.16x | 31.41x | 38.92x | 22.04x | 24.58x | 7.18x |
| Quick Ratio | 23.01x | 30.61x | 37.70x | 20.27x | 26.76x | 6.69x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -26.0% | -24.1% | -35.6% | -37.3% | -28.7% | -25.2% | -48.1% | -34.9% |
| Return on Assets (ROA) | -25.1% | -23.4% | -34.6% | -35.7% | -27.8% | -24.3% | -46.3% | -34.0% |
| Current Ratio | 26.58x | 31.45x | 27.86x | 15.16x | 18.38x | 14.08x | 14.25x | 31.41x |
| Quick Ratio | 25.98x | 30.86x | 26.91x | 23.01x | 17.56x | 13.65x | 13.94x | 30.61x |
| Debt to Equity | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
